John Ingram, PhD, MD
Cardiff University
BIOGRAPHY
Professor Dr John Ingram runs a HS multidisciplinary team clinic in Cardiff, UK, integrating medical, surgical and targeted treatments. He led the 2018 UK guideline development group for HS, as well as the Cochrane Review of ‘Interventions for HS’ and is a founding member of HiSTORIC, the HIdradenitis SuppuraTiva cORe outcomes set International Collaboration. He is also Immediate-Past Editor-in-Chief of the British Journal of Dermatology.
SESSIONS
DISCLOSURES
AbbVie – Consultant(Honoraria); Bluefin Biomedicine – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Consultant(Honoraria); British Journal of Dermatology – Other(Honoraria); Cantargia – Consultant (1099 relationship)(Honoraria); ChemoCentryx – Consultant(Honoraria); Citryll – Consultant(Honoraria); Elasmogen – Consultant (1099 relationship)(Honoraria); Engitix – Consultant (1099 relationship)(Honoraria); Incyte – Consultant (1099 relationship)(Honoraria); Indero, Inc. – Consultant (1099 relationship)(Honoraria); InflaRx – Consultant (1099 relationship)(Honoraria); Insmed Incorporated – Advisory Board(Honoraria); Kymera Therapeutics – Advisory Board(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); Novartis – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); Union Therapeutics – Consultant (1099 relationship)(Honoraria); Viela Bio – Advisory Board(Honoraria);